Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.
Schlaepfer IR, Rider L, Rodrigues LU, Gij?n MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glod? LM, Eckel RH, Cramer SD. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol Cancer Ther. 2014 Oct; 13(10):2361-71.